ArticleJournal of breast cancer2026
Tall Cell Carcinoma With Reversed Polarity of the Breast: A Case Report.
Article in Journal of breast cancer, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Tall cell carcinoma with reversed polarity (TCCRP) of the breast is a rare malignant neoplasm that shares morphological similarities with the tall-cell variant of papillary thyroid carcinoma, which may lead to diagnostic confusion. Immunohistochemical and molecular analyses are essential to confirm mammary origin and exclude metastatic thyroid carcinoma. Herein, we report a case of a 62-year-old woman, who was diagnosed with TCCRP based on characteristic histomorphological features and immunohistochemical findings in a breast mass. Despite exhibiting a triple-negative immunophenotype, TCCRP is associated with an indolent clinical course. Accurate diagnosis requires integration of morphological, immunohistochemical, and molecular features, which are critical for appropriate classification and may help support a more conservative management approach.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.